Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Pharm Res. 2012 Feb;29(2):535-45. doi: 10.1007/s11095-011-0580-9. Epub 2011 Sep 9.
To determine if fasting would affect the intestinal expression and in vivo functional activity of PEPT1 as determined after oral dosing of the dipeptide glycylsarcosine (GlySar).
Systemic exposure and tissue distribution studies were performed in wild-type and Pept1 knockout mice, under fed and fasted conditions, following both intravenous and oral doses of [(14)C]GlySar at 5 nmol/g body weight. Intestinal PEPT1 expression was evaluated by real-time PCR and immunoblot analyses.
We found that expression of PEPT1 protein in the small intestine was increased ~2-fold in wild-type mice during fasted as compared to fed conditions. In agreement, systemic exposure and peak plasma concentrations of orally administered GlySar were 40 and 65% greater, respectively, in wild-type mice during fasted vs. fed state. No significant differences were observed between fed and fasted animals during PEPT1 ablation. Tissue distribution of GlySar was unchanged after oral dosing for all four treatment groups.
As little as 16 h of fasting can cause significant upregulation of PEPT1 protein expression in the small intestine, which then translates into a significant increase in in vivo oral absorption of GlySar.
确定禁食是否会影响 PEPT1 的肠道表达和体内功能活性,方法是在口服二肽甘氨酰-肌氨酸(GlySar)后进行检测。
在给予 5 nmol/g 体重的 [(14)C]GlySar 静脉内和口服剂量后,在进食和禁食条件下,在野生型和 Pept1 敲除小鼠中进行全身暴露和组织分布研究。通过实时 PCR 和免疫印迹分析评估肠道 PEPT1 表达。
我们发现,与进食状态相比,在禁食状态下,野生型小鼠小肠中 PEPT1 蛋白的表达增加了约 2 倍。一致地,口服给予 GlySar 的全身暴露和血浆峰浓度分别在野生型小鼠禁食状态下比进食状态下增加了 40%和 65%。在 PEPT1 缺失的情况下,在进食和禁食动物之间未观察到显着差异。口服给予所有 4 个治疗组后,GlySar 的组织分布没有变化。
仅禁食 16 小时就会导致小肠中 PEPT1 蛋白表达的显着上调,从而导致 GlySar 的体内口服吸收显着增加。